MX346473B - Procesos cromatograficos y compuestos purificados de los mismos. - Google Patents
Procesos cromatograficos y compuestos purificados de los mismos.Info
- Publication number
- MX346473B MX346473B MX2012001824A MX2012001824A MX346473B MX 346473 B MX346473 B MX 346473B MX 2012001824 A MX2012001824 A MX 2012001824A MX 2012001824 A MX2012001824 A MX 2012001824A MX 346473 B MX346473 B MX 346473B
- Authority
- MX
- Mexico
- Prior art keywords
- ion
- purified compounds
- pairing agents
- chromatographic processes
- preparative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a la utilidad de los agentes de apareamiento jónico en la escala preparativa de purificación. Más particularmente, la descripción se refiere al uso de agentes de apareamiento jónico en cromatografía lineal preparativa RP permitiendo alta pureza del producto final deseado. La descripción muestra que los agentes de apareamiento iónico tienen un efecto dramático en la pureza deseada de polipéptidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1908CH2009 | 2009-08-11 | ||
PCT/IB2010/053589 WO2011018745A1 (en) | 2009-08-11 | 2010-08-09 | Chromatographic processes and purified compounds thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012001824A MX2012001824A (es) | 2012-03-07 |
MX346473B true MX346473B (es) | 2017-03-22 |
Family
ID=43585994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012001824A MX346473B (es) | 2009-08-11 | 2010-08-09 | Procesos cromatograficos y compuestos purificados de los mismos. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20120178900A1 (es) |
EP (1) | EP2464655B1 (es) |
JP (1) | JP6169354B2 (es) |
KR (1) | KR20120055653A (es) |
CN (1) | CN102471368A (es) |
BR (1) | BR112012002934B1 (es) |
ES (1) | ES2625125T3 (es) |
IL (1) | IL217999B (es) |
MX (1) | MX346473B (es) |
MY (1) | MY186089A (es) |
PL (1) | PL2464655T3 (es) |
PT (1) | PT2464655T (es) |
RU (1) | RU2508294C2 (es) |
SG (1) | SG178306A1 (es) |
WO (1) | WO2011018745A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102471367A (zh) * | 2009-07-09 | 2012-05-23 | 拜康有限公司 | 一种制备非线性梯度色谱法及其纯化的产物 |
CN102584953B (zh) * | 2012-02-09 | 2014-01-01 | 深圳翰宇药业股份有限公司 | 一种阿托西班的纯化方法 |
CN102702321A (zh) * | 2012-06-14 | 2012-10-03 | 吉尔生化(上海)有限公司 | 一种纯化依非巴特的方法 |
US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
CN112717125A (zh) * | 2012-10-03 | 2021-04-30 | 瑞士杰特贝林生物制品有限公司 | 一种纯化蛋白质的方法 |
TWI659209B (zh) | 2013-06-17 | 2019-05-11 | 地平線罕見醫學製藥有限責任公司 | 分析半胱胺組合物的方法 |
CN103980350B (zh) * | 2013-09-10 | 2018-01-09 | 杭州阿诺生物医药科技股份有限公司 | 一种固环合成阿托西班的方法 |
JP6709024B2 (ja) * | 2015-07-03 | 2020-06-10 | 国立研究開発法人医薬基盤・健康・栄養研究所 | ペプチド又はタンパク質の分画方法 |
CN105111305B (zh) * | 2015-10-10 | 2018-12-14 | 山东阿华生物药业有限公司 | 酰化胰岛素的色谱纯化方法 |
CN107312072A (zh) * | 2017-06-20 | 2017-11-03 | 浙江湃肽生物有限公司 | 一种纯化分离阿托西班的方法 |
EP3841106A4 (en) | 2018-08-20 | 2022-08-10 | Biocon Biologics Limited | CHROMATOGRAPHY METHOD FOR PURIFYING INSULIN ANALOGS |
JP6564539B1 (ja) * | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | スルホン酸化合物によるペプチド精製方法 |
CN109942686B (zh) * | 2019-05-06 | 2021-06-25 | 上海上药第一生化药业有限公司 | 一种加压素乙酰化杂质的精制方法 |
CN110016070B (zh) * | 2019-05-06 | 2021-07-20 | 上海上药第一生化药业有限公司 | 一种加压素[+Gly]杂质的精制方法 |
CN110028556B (zh) * | 2019-05-07 | 2021-04-13 | 上海上药第一生化药业有限公司 | 一种缩宫素[-nh2]杂质的精制方法 |
CN110078796B (zh) * | 2019-05-07 | 2021-04-13 | 上海上药第一生化药业有限公司 | 一种缩宫素[4-Glu,5-Asp]杂质的精制方法 |
CN110066319B (zh) * | 2019-05-07 | 2021-04-06 | 上海上药第一生化药业有限公司 | 一种缩宫素乙酰化杂质的精制方法 |
CN110078797B (zh) * | 2019-05-07 | 2021-04-13 | 上海上药第一生化药业有限公司 | 一种缩宫素[4-Glu]杂质的精制方法 |
CN110041405B (zh) * | 2019-05-07 | 2021-04-13 | 上海上药第一生化药业有限公司 | 一种缩宫素[5-Asp]杂质的精制方法 |
CN110041406B (zh) * | 2019-05-07 | 2021-04-13 | 上海上药第一生化药业有限公司 | 一种缩宫素[+Gly]杂质的精制方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4028120C2 (de) * | 1990-09-05 | 1996-09-19 | Hoechst Ag | Verfahren zur Reinigung von Insulin und/oder Insulinderivaten |
US5208041A (en) * | 1991-05-23 | 1993-05-04 | Allelix Biopharmaceuticals Inc. | Essentially pure human parathyroid hormone |
US5290920A (en) * | 1992-04-16 | 1994-03-01 | Allelix Biopharmaceuticals Inc. | Method of purifying human epidermal growth factor |
US5504188A (en) * | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
ES2242270T3 (es) * | 1997-02-07 | 2005-11-01 | Novo Nordisk A/S | Cristalizacion de proteinas. |
HUP0000547A3 (en) * | 1997-03-20 | 2002-11-28 | Novo Nordisk As | Zinc free insulin crystals for use in pulmonary compositions |
ATE464390T1 (de) * | 2001-11-19 | 2010-04-15 | Novo Nordisk As | Verfahren zur herstellung von insulinverbindungen |
KR20040070237A (ko) * | 2001-12-20 | 2004-08-06 | 일라이 릴리 앤드 캄파니 | 연장된 작용 시간을 갖는 인슐린 분자 |
DE10235168A1 (de) * | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
PT1511761E (pt) * | 2003-04-07 | 2006-11-30 | Novetide Ltd | Processo para produção peptídeos cíclicos |
JP2007513192A (ja) * | 2004-10-04 | 2007-05-24 | ノベタイド,リミティド | ペプチド用の対イオン交換法 |
JP2008534628A (ja) * | 2005-05-03 | 2008-08-28 | ノベタイド,リミティド | ペプチド誘導体の製造のための方法 |
US8067533B2 (en) * | 2006-02-23 | 2011-11-29 | Fibrex Medical Research & Development Gmbh | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
KR101257330B1 (ko) * | 2008-02-06 | 2013-04-23 | 바이오콘 리미티드 | 펩타이드 정제 방법 |
-
2010
- 2010-08-09 CN CN2010800357019A patent/CN102471368A/zh active Pending
- 2010-08-09 RU RU2012108039/04A patent/RU2508294C2/ru active
- 2010-08-09 MX MX2012001824A patent/MX346473B/es active IP Right Grant
- 2010-08-09 US US13/390,094 patent/US20120178900A1/en not_active Abandoned
- 2010-08-09 PT PT108080359T patent/PT2464655T/pt unknown
- 2010-08-09 BR BR112012002934-7A patent/BR112012002934B1/pt active IP Right Grant
- 2010-08-09 KR KR1020127006320A patent/KR20120055653A/ko not_active Application Discontinuation
- 2010-08-09 MY MYPI2012000531A patent/MY186089A/en unknown
- 2010-08-09 SG SG2012008587A patent/SG178306A1/en unknown
- 2010-08-09 EP EP10808035.9A patent/EP2464655B1/en active Active
- 2010-08-09 ES ES10808035.9T patent/ES2625125T3/es active Active
- 2010-08-09 PL PL10808035T patent/PL2464655T3/pl unknown
- 2010-08-09 JP JP2012524318A patent/JP6169354B2/ja active Active
- 2010-08-09 WO PCT/IB2010/053589 patent/WO2011018745A1/en active Application Filing
-
2012
- 2012-02-09 IL IL217999A patent/IL217999B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP6169354B2 (ja) | 2017-07-26 |
ES2625125T3 (es) | 2017-07-18 |
MX2012001824A (es) | 2012-03-07 |
MY186089A (en) | 2021-06-21 |
CN102471368A (zh) | 2012-05-23 |
BR112012002934A2 (pt) | 2016-04-05 |
BR112012002934B1 (pt) | 2021-12-21 |
IL217999A0 (en) | 2012-04-30 |
EP2464655A4 (en) | 2013-04-24 |
KR20120055653A (ko) | 2012-05-31 |
WO2011018745A1 (en) | 2011-02-17 |
US20120178900A1 (en) | 2012-07-12 |
SG178306A1 (en) | 2012-03-29 |
RU2508294C2 (ru) | 2014-02-27 |
RU2012108039A (ru) | 2013-09-20 |
IL217999B (en) | 2018-01-31 |
EP2464655A1 (en) | 2012-06-20 |
EP2464655B1 (en) | 2017-02-15 |
JP2013501773A (ja) | 2013-01-17 |
PL2464655T3 (pl) | 2017-08-31 |
PT2464655T (pt) | 2017-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY186089A (en) | Chromatographic processes and purified compounds thereof | |
TW200716557A (en) | Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof | |
MX2013003182A (es) | Purificacion de anticuerpos por cromatografia de lecho movil simulada. | |
IN2012DN02313A (es) | ||
IL189994A0 (en) | Production and purification of il-29 | |
UA94837C2 (ru) | Способ синтеза (7-метокси-1-нафтил)ацетонитрила и применение в синтезе агомелатина | |
MY194466A (en) | Heterophasic polypropylene composition | |
MX342444B (es) | Metodo para purificar eritropoyetina conjugada con polietilenglicol (peg). | |
WO2015021423A3 (en) | Purification of chimeric fviii molecules | |
IL187935A0 (en) | Process for the purification of il-18 binding protein | |
EP2231574A4 (en) | PROCESS FOR THE PURIFICATION OF 1,1,1,3,3,3-HEXAFLUORO-ISOPROPYL ETHER FLUOROMETHYL (SEVOFLURAN) | |
MX2015012809A (es) | Procedimiento para la elaboracion de gadofosveset trisodico monohidratado. | |
MX2011012623A (es) | Construcciones de casb7439. | |
MD20160071A2 (ro) | Procedeu nou de sinteză a agomelatinei | |
WO2011063195A3 (en) | Purification of modified cytokines | |
MX2009011207A (es) | Eteres de amidas de acido naftalen-carboxilico como cura para el cancer. | |
GB0806039D0 (en) | Reversed endcapping and bonding of HPLC phases using hydrosilanes | |
WO2011156369A3 (en) | Purification of modified cytokines | |
NZ708503A (en) | Purification of x-ray contrast agents | |
MX2011008931A (es) | Un proceso para la preparacion eco-amigable de 3,5-dibromo-4-hidroxibenzonitrilo. | |
NZ709541A (en) | Compounds and methods for purification of serine proteases | |
IN2014CH01392A (es) | ||
CL2012001488A1 (es) | Metodo para separar impureza ionica de corriente de proceso que contiene monosacaridos que comprende a. poner en contacto resina de exclusion ionica dentro de unidad de cromatografia en lecho movil simulado con corriente del proceso que contiene monosacarido, y b. eluir obteniendo corriente de dicho monosacarido y corriente de impureza ionica ; l-glucosa; composicion farmaceutica; y metodo de limpieza de colon. | |
IL199752A0 (en) | Purification of taci-fc | |
AU2010294240A8 (en) | PLGF-1 in homodimeric form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |